Gabapentin Capsules
Product Description
Jiangsu Hengrui Medicine Co., Ltd.
-
CN -
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Categories
Specifications
Jiangsu Hengrui Medicine Co., Ltd.
-
CN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
More Products from Jiangsu Hengrui Medicine Co., Ltd. (99)
-
Product Zolmitriptan
Zolmitriptan is a selective serotonin receptor agonist of the 1B and 1D subtypes. It is a triptan, used in the acute treatment of migraine attacks with or without aura and cluster headaches.
It is in R&D stage.
-
Product Abiraterone Acetate tablets
This product is indicated for Prostaglandin carcinoma.
Strength: 250mg
Standard: In-House -
Product Caspofungin Acetate for Injection
Caspofungin Acetate for Injection, is one of the main products of our company’s anti-infection products’ line which mainly applied in treatment of infection caused by various fungi.
Strength: 50mg/vial; 70mg/vial.
This product is approved by MNPA.
It is approved by US-FDA, and Ne... -
Product Cisatracurium Besylate Injection
Cisatracurium is used adjunctively inanesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Strength: 10mg/5ml; 200mg/20ml (10mg/ml).
This product has been appr... -
Product Cyclophosphamide for Injection
Cyclophosphamide is a medication mainly used in chemotherapy. It is an alkylating agent of the nitrogen mustard type (specifically, the oxazaphosphorine group). It is used to treat cancers, autoimmune disorders and AL amyloidosis. As a prodrug, it is c... -
Product Docetaxel Injection
It is used for treatment of locally advanced or metastatic breast cancer, head and neck cancer, gastric cancer, hormone-refractory prostate cancer and non small-cell lung cancer.
Strength: 20mg/1ml; 80mg/4ml;160mg/8ml---US FDA and NMPA approved.
Strength: 20mg/0.5 ml ... -
Product Irinotecan HCl Injection
The main use of this product is in colon cancer, in particular, in combination with other chemotherapy agents.
Strength: 40mg/2ml; 100mg/5ml.
NMPA approved.
MA issued from US-FDA, Japanese PMDA.
-
Product Letrozole Tablets
Letrozole is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
Strength: 2.5mg.
Letrozole Tablets is approved by NMPA and EU GMP (Spain and Netherlands), and have MA issued from US-F... -
Product Oxaliplatin for Injection
Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.
Strength: 50mg/vial.
It is the first injection product of domestic pharmaceutical enterprises approved to get launched in the European market.
MA issued from Spain, Netherlands CBG and UK MH... -
Product Fondaparinux Injection
Fondaparinux is an anticoagulant medication chemically related to low molecular weight heparins.
Strength: 0.5ml:2.5mg; 0.4ml:0.5mg; 0.6ml:7.5mg; 0.8ml:10mg.
It is approved by US-FDA. -
Product Thiotepa for Injection
Thiotepa for Injection USP is an alkylating agentused to treat cancer.
Strength: 15mg/vial
Approved by US-FDA.
Dossiers for EU market have been filed.
-
Product Lopamidol Injection
It is a kind of contrast agent.
Strength:
(300mg iodine/ml) 61% *50ml *100ml
(370mg iodine/ml) 76% *50ml *100ml *150ml *200ml
It is in R&D stage.
Jiangsu Hengrui Medicine Co., Ltd. resources (1)
-
Brochure Hengrui Medicine - Company Details
Hengrui Medicine is dedicated to research, developing, and promoting innovative medicine with high quality.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance